These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

298 related items for PubMed ID: 2539411

  • 1. Preferential binding of the neutrophil cytoplasmic granule-derived bactericidal/permeability increasing protein to target bacteria. Implications and use as a means of purification.
    Mannion BA, Kalatzis ES, Weiss J, Elsbach P.
    J Immunol; 1989 Apr 15; 142(8):2807-12. PubMed ID: 2539411
    [Abstract] [Full Text] [Related]

  • 2. Human granulocytes express a 55-kDa lipopolysaccharide-binding protein on the cell surface that is identical to the bactericidal/permeability-increasing protein.
    Weersink AJ, van Kessel KP, van den Tol ME, van Strijp JA, Torensma R, Verhoef J, Elsbach P, Weiss J.
    J Immunol; 1993 Jan 01; 150(1):253-63. PubMed ID: 7678030
    [Abstract] [Full Text] [Related]

  • 3. Antibacterial proteins of granulocytes differ in interaction with endotoxin. Comparison of bactericidal/permeability-increasing protein, p15s, and defensins.
    Levy O, Ooi CE, Elsbach P, Doerfler ME, Lehrer RI, Weiss J.
    J Immunol; 1995 May 15; 154(10):5403-10. PubMed ID: 7730641
    [Abstract] [Full Text] [Related]

  • 4. The role of lipopolysaccharides in the action of the bactericidal/permeability-increasing neutrophil protein on the bacterial envelope.
    Weiss J, Muello K, Victor M, Elsbach P.
    J Immunol; 1984 Jun 15; 132(6):3109-15. PubMed ID: 6373924
    [Abstract] [Full Text] [Related]

  • 5. The bactericidal/permeability increasing protein of neutrophils is a potent antibacterial and anti-endotoxin agent in vitro and in vivo.
    Elsbach P, Weiss J, Doerfler M, Shu C, Kohn F, Ammons WS, Kung AH, Meszaros KK, Parent JB.
    Prog Clin Biol Res; 1994 Jun 15; 388():41-51. PubMed ID: 7831373
    [Abstract] [Full Text] [Related]

  • 6. The bactericidal/permeability-increasing protein (BPI), a potent element in host-defense against gram-negative bacteria and lipopolysaccharide.
    Elsbach P, Weiss J.
    Immunobiology; 1993 Apr 15; 187(3-5):417-29. PubMed ID: 8330906
    [Abstract] [Full Text] [Related]

  • 7. Bactericidal/permeability-increasing protein has endotoxin-neutralizing activity.
    Marra MN, Wilde CG, Griffith JE, Snable JL, Scott RW.
    J Immunol; 1990 Jan 15; 144(2):662-6. PubMed ID: 2295804
    [Abstract] [Full Text] [Related]

  • 8. The role of bactericidal/permeability-increasing protein as a natural inhibitor of bacterial endotoxin.
    Marra MN, Wilde CG, Collins MS, Snable JL, Thornton MB, Scott RW.
    J Immunol; 1992 Jan 15; 148(2):532-7. PubMed ID: 1729370
    [Abstract] [Full Text] [Related]

  • 9. All-trans retinoic acid-induced expression of bactericidal/permeability-increasing protein (BPI) in human myeloid cells correlates to binding of C/EBPbeta and C/EBPepsilon to the BPI promoter.
    Lennartsson A, Vidovic K, Pass MB, Cowland JB, Gullberg U.
    J Leukoc Biol; 2006 Jul 15; 80(1):196-203. PubMed ID: 16684888
    [Abstract] [Full Text] [Related]

  • 10. A peptide derived from human bactericidal/permeability-increasing protein (BPI) exerts bactericidal activity against Gram-negative bacterial isolates obtained from clinical cases of bovine mastitis.
    Chockalingam A, McKinney CE, Rinaldi M, Zarlenga DS, Bannerman DD.
    Vet Microbiol; 2007 Nov 15; 125(1-2):80-90. PubMed ID: 17560054
    [Abstract] [Full Text] [Related]

  • 11. Impaired innate immunity in the newborn: newborn neutrophils are deficient in bactericidal/permeability-increasing protein.
    Levy O, Martin S, Eichenwald E, Ganz T, Valore E, Carroll SF, Lee K, Goldmann D, Thorne GM.
    Pediatrics; 1999 Dec 15; 104(6):1327-33. PubMed ID: 10585984
    [Abstract] [Full Text] [Related]

  • 12. Presence of bactericidal/permeability-increasing protein in human and rat skin.
    Takahashi M, Horiuchi Y, Tezuka T.
    Exp Dermatol; 2004 Jan 15; 13(1):55-60. PubMed ID: 15009116
    [Abstract] [Full Text] [Related]

  • 13. The endotoxin-binding bactericidal/permeability-increasing protein (BPI): a target antigen of autoantibodies.
    Schultz H, Weiss J, Carroll SF, Gross WL.
    J Leukoc Biol; 2001 Apr 15; 69(4):505-12. PubMed ID: 11310835
    [Abstract] [Full Text] [Related]

  • 14. Separation of sublethal and lethal effects of the bactericidal/permeability increasing protein on Escherichia coli.
    Mannion BA, Weiss J, Elsbach P.
    J Clin Invest; 1990 Mar 15; 85(3):853-60. PubMed ID: 2179269
    [Abstract] [Full Text] [Related]

  • 15. Bactericidal/permeability-increasing protein and cathepsin G are the major antigenic targets of antineutrophil cytoplasmic autoantibodies in systemic sclerosis.
    Khanna D, Aggarwal A, Bhakuni DS, Dayal R, Misra R.
    J Rheumatol; 2003 Jun 15; 30(6):1248-52. PubMed ID: 12784398
    [Abstract] [Full Text] [Related]

  • 16. A murine antibacterial ortholog to human bactericidal/permeability-increasing protein (BPI) is expressed in testis, epididymis, and bone marrow.
    Lennartsson A, Pieters K, Vidovic K, Gullberg U.
    J Leukoc Biol; 2005 Mar 15; 77(3):369-77. PubMed ID: 15590754
    [Abstract] [Full Text] [Related]

  • 17. Both N- and C-terminal regions of the bioactive N-terminal fragment of the neutrophil granule bactericidal/permeability-increasing protein are required for stability and function.
    Capodici C, Weiss J.
    J Immunol; 1996 Jun 15; 156(12):4789-96. PubMed ID: 8648126
    [Abstract] [Full Text] [Related]

  • 18. Individual and synergistic effects of rabbit granulocyte proteins on Escherichia coli.
    Levy O, Ooi CE, Weiss J, Lehrer RI, Elsbach P.
    J Clin Invest; 1994 Aug 15; 94(2):672-82. PubMed ID: 8040321
    [Abstract] [Full Text] [Related]

  • 19. Isolation of two isoforms of a novel 15-kDa protein from rabbit polymorphonuclear leukocytes that modulate the antibacterial actions of other leukocyte proteins.
    Ooi CE, Weiss J, Levy O, Elsbach P.
    J Biol Chem; 1990 Sep 15; 265(26):15956-62. PubMed ID: 2203792
    [Abstract] [Full Text] [Related]

  • 20. Antagonistic effects of lipopolysaccharide binding protein and bactericidal/permeability-increasing protein on lipopolysaccharide-induced cytokine release by mononuclear phagocytes. Competition for binding to lipopolysaccharide.
    Dentener MA, Von Asmuth EJ, Francot GJ, Marra MN, Buurman WA.
    J Immunol; 1993 Oct 15; 151(8):4258-65. PubMed ID: 8409400
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.